Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-041331
Filing Date
2013-08-19
Accepted
2013-08-19 16:16:16
Documents
1
Period of Report
2013-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10754
  Complete submission text file 0001209191-13-041331.txt   11971
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MUELLER PETER (Reporting) CIK: 0001256126 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 131048454